Advertisement
Advertisement

FATE

FATE logo

Fate Therapeutics Inc

1.68
USD
-0.075
-4.29%
Jan 08, 15:58 UTC -5
Closed
exchange

After-Market

1.68

+0.005
+0.30%

FATE Cash Flow


Expand Categories

ItemTTM
12/31/202312/31/202212/31/2021
Cash Flow From Operating Activities
-131.712-132.263-248.208-162.87
Consolidated Net Income (Loss)
-46.63-160.928-281.721-212.151
Total Non-Cash Items
50.7579.48368.22347.183
Total Amortization
-10.456-4.2022.429.062
Amortization of Intangible Assets
-10.456-4.2022.429.062
Stock-Based Compensation
41.85143.45978.73354.364
Other Non-Cash Items
-0.614-48.056-26.688-22.093
Total Changes in Assets/Liabilities
-4.23819.182-34.712.098
Change in Accounts Receivable
-1.98936.654-29.804-3.16
Change in Accounts Payable & Accrued Liability
-4.209-28.9414.2525.907
Change in Assets/Liabilities
1.9611.468-19.158-0.649
Cash Flow From Investing Activities
34.755112.665166.751-324.023
Net Change in PP&E
-0.813-6.153-35.566-50.704
Capital Expenditures
-0.813-6.153-35.566-50.704
Net Change in Investments - Total
35.568118.818202.317-273.319
Net Change in Short-Term Investments
35.568118.818202.317-273.319
Cash Flow From Financing Activities
96.5820.0859.207453.129
Net Total Equity Issued (Repurchased)
94.6420.0859.207453.129
Net Common Equity Issued (Repurchased)
94.6420.0859.207453.129
Common Shares Issued
94.6420.0859.207453.129
Increase (Decrease) in Cash
-0.375-19.513-72.25-33.764
Beginning Cash
57.04776.56148.81182.574
End Cash
56.67257.04776.56148.81

In Millions of USD (except for per share items).

Advertisement